FOLFIRI.3 regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFIRI.3 regimen, covering 2024-07-09 to 2024-07-09. Get the full timeline:
Most recent: Clinical Trial Update: FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine [Phase 2]